Skip to content
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Menu
Menu
Toggle Menu
Change Country
Our Stories
Latest News
Innovation
Caring & Giving
Personal Stories
Health & Wellness
Our Heritage
Our Company
About J&J
Our Credo
Our Leadership Team
Code of Business Conduct
Corporate Reports
Diversity, Equity & Inclusion
ESG Policies & Positions
Innovation at J&J
J&J Health and Wellness Solutions
Office of the Chief Medical Officer
Veterans, Military & Military Families
Products
MedTech
Pharmaceutical Products
Suppliers
Responsibility Supply Base
Supplier-Enabled Innovation
Supplier Resources
Careers
What We Do
How We Hire
Job Spotlight
Employee Benefits
Students
Innovation
Career Stories
Media Center
Investors
2023 Annual Meeting of Shareholders
Corporate Governance
Quarterly Results
SEC Filings
News Releases
Pharmaceutical Pipeline
2022 Janssen Transparency Report
2022 Health for Humanity Report
ESG Resources
Stock Information
Webcasts & Presentations
Investor Fact Sheet
Our Societal Impact
Global Community Impact
Global Public Health
Global Environmental Sustainability
Close Countries Menu
Explore more Johnson & Johnson sites:
China
France
Germany
India
Japan
Russia
Switzerland
German
English
French
United Kingdom
United States
Search input
Dictate search request
Empty search box
Recently Viewed
Top Searches
Our Leadership Team
Committees of the Board of Directors
Share
Investor Information
Get the latest news, conference announcements, press releases and company performance information to be an informed shareholder.
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
Learn More
Johnson & Johnson to Participate in the Morgan Stanley 21
st
Annual Global Healthcare Conference
Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference
Listen to Webcast: Johnson & Johnson Participates in the UBS MedTech, Tools and Genomics Summit
:
(
%)
Day High
Day Low
Volume
N/A
Last Updated:
2023 Annual Meeting of Shareholders
2023 Annual Meeting of Shareholders
Annual Meeting Materials and Webcast
Johnson & Johnson Updated Financials & 2023 Guidance Following Completion of the Kenvue Separation
Johnson & Johnson Updated Financials & 2023 Guidance Following Completion of the Kenvue Separation
Listen to Webinar
Latest News Releases
Financial
September 18, 2023
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
Financial
August 23, 2023
Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.
Latest News
August 22, 2023
Johnson & Johnson to Participate in the Morgan Stanley 21
st
Annual Global Healthcare Conference
See All News Releases
ON NOW
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
Webcast: Pharmaceutical Business Review 2021
ON NOW
2022 Health for Humanity Report
2022 Health for Humanity Report
2022 Health for Humanity Report
ON NOW
2022 Janssen U.S. Transparency Report
2022 Janssen U.S. Transparency Report
2022 Janssen U.S. Transparency Report
ON NOW
2022 Annual Report
2022 Annual Report
Investor Relations
ON NOW
Corporate Governance
Corporate Governance
Corporate Governance
ON NOW
SEC Filings
SEC Filings
SEC Filings
ON NOW
Pharmaceutical Pipeline
Pharmaceutical Pipeline
Pharmaceutical Pipeline
ON NOW
Stock Information
Stock Information
Stock Information
ON NOW
Webcasts & Presentations
Webcasts & Presentations
Webcasts & Presentations
ON NOW
Investor Fact Sheet
Investor Fact Sheet
Investor Fact Sheet
Quarterly Results
See the latest quarterly sales and earnings from Johnson & Johnson, as well as historical results covering the past ten years.
Learn More
Shareholder Tools
Email Alerts Subscription
RSS News Feeds
Investor FAQs
Answers to common questions regarding purchasing and owning Johnson & Johnson stock.
Learn More
ESG Resources
Effective management of ESG matters is a business imperative.
Learn More
Contact Investor Relations
Questions? Please contact us:
1-800-950-5089
investor-relations@its.jnj.com
Learn more about our Guidelines for Communication with the Investment Community (Reg FD)
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue